Not provided
Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 16/HRA/3327 | Other Identifier | Integrated Research Application System |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Guy's and St Thomas' NHS Foundation Trust | OTHER |
| King's College Hospital NHS Trust | OTHER |
| Oxford University Hospitals NHS Trust | OTHER |
| University College London Hospitals |
Not provided
Not provided
Not provided
Not provided
The National Institute for Health Research (NIHR) Cardiovascular Health Informatics Collaborative is an observational, multi-centre and longitudinal study of clinical data from collaborating hospitals. A dataset of the longitudinal record for patients who presented with a suspected acute coronary syndrome, characterised by the request of a troponin test, has been developed (NHIC-Troponin Study).
The NHIC Cardiovascular Project in the United Kingdom was established to enable the sharing and repurposing of routinely captured clinical data for re-use in research. Data sharing for this study has been enabled by establishing a data sharing agreement between each of the collaborating hospitals. The data sharing agreement allows data to be shared between National Health Service (NHS) hospitals in accordance with an anonymisation and de-identification profile approved by each information governance department, ensuring that patient identities are protected. Ethics approval for each dataset has been obtained which detailed the further de-identification steps to ensure that research datasets are fully anonymised.
The cardiovascular theme clinical leads developed a standard target data model specification to capture the longitudinal record for patients who presented with a suspected acute coronary syndrome, characterised by the request of a troponin test (NHIC-Troponin Study). The data model was patient centric allowing for minor discrepancies between dataset areas such as missing discharges or test results returning outside of episodes of care. The model included 156 data points, grouped into demographics, cardiovascular risk factors, emergency department attendance and inpatient episodes, biochemistry, revascularisation and mortality. All patients were followed up on the NHS Spine Application, Summary Care Record until death or censoring on 1st April 2017.
This dataset comprised all patients who had a troponin measured at each of the five major academic centres between 2010 (2008 for University College Hospital) and 2017. The investigators identified a total of 257948 patient records who underwent troponin testing during the study period.
A Committee of Experts validates the protocol methodology and supervises the data management. A Steering Committee oversees study proposals including hypotheses, study design and statistical analyses including planned outcome measures.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Unselected cohort of patients who had a troponin measured | Patients who presented to hospital during the study period (2010-17) and had at least one troponin blood test measured. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Mortality, All-cause | Number of patients who died (from any cause) including in-hospital, short-term and long-term mortality | Hospital admission to 3 years follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Acute Revascularisation | Acute revascularisation will be defined as having PCI or CABG in the time window between 48 hours before and 3 months after the first troponin measurement. This will account for patients who had revascularisation, in particular PCI, as an emergency prior to their first troponin blood test and to capture revascularisation, in particular CABG, performed as an outpatient following their index admission. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All patients with electronic records at collaborating hospitals.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jamil Mayet | Imperial College London | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42264918 | Derived | Collard D, Chen Y, Kaura A, Mulla A, Glampson B, Davies J, Papadimitriou D, Woods K, O'Gallagher K, Mayer E, Lee R, Herbert C, Grant SW, Curzen N, Squire I, Johnson T, Shah AM, Perera D, Kharbanda RK, Channon K, Williams B, Hemingway H, Hingorani AD, Asselbergs FW, Mayet J, Shah AD, Patel RS. Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment. Heart. 2026 Jun 9:heartjnl-2025-327658. doi: 10.1136/heartjnl-2025-327658. Online ahead of print. | |
| 39384342 |
| Label | URL |
|---|---|
| Creating 'big data' from health records to improve care | View source |
Not provided
De-identified individual electronic patient record data for all primary and secondary outcome measures will be made available.
Data will me made available from study completion date.
Data access requests will be reviewed by a Steering Committee from the participating Biomedical Research Centres. Requesters will be required to sign a Data Access Agreement.
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Unselected Cohort of Patients Who Had a Troponin Measured | A total of 257 948 patients who presented to hospital during the study period (2010-17) and had at least one troponin blood test measured. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Unselected Cohort of Patients Who Had a Troponin Measured | A total of 257 948 patients who presented to hospital during the study period (2010-17) and had at least one troponin blood test measured. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Median |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Mortality, All-cause | Number of patients who died (from any cause) including in-hospital, short-term and long-term mortality | Posted | Count of Participants | Participants | Hospital admission to 3 years follow-up |
|
|
Last refresh for troponin dataset was April 2017, reflecting 7 years of follow-up
As the National Institute for Health Research Health Informatics Collaborative (NIHR HIC) involves collecting routine patient data from electronic health care records, there are no adverse events being collected in relation to a new intervention as part of a trial. The only adverse event that was routinely collected for all patients was all-cause mortality.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Unselected Cohort of Patients Who Had a Troponin Measured | A total of 257 948 patients who presented to hospital during the study period (2010-17) and had at least one troponin blood test measured. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr Amit Kaura | Imperial College Healthcare NHS Trust | 020 3312 6666 | amit.kaura@nhs.net |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jul 4, 2024 | Jul 5, 2024 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D054058 | Acute Coronary Syndrome |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
| OTHER |
| University Hospital Southampton NHS Foundation Trust | OTHER |
| University Hospitals, Leicester | OTHER |
| University Hospitals Bristol and Weston NHS Foundation Trust | OTHER |
| Manchester University NHS Foundation Trust | OTHER_GOV |
| University Hospital Birmingham NHS Foundation Trust | OTHER |
| The Leeds Teaching Hospitals NHS Trust | OTHER |
| Blackpool Teaching Hospitals NHS Foundation Trust | OTHER |
Not provided
Not provided
Not provided
| 3 months follow-up |
| Derived |
| Scott JK, Johnson T, Caskey FJ, Bailey P, Selman LE, Mulla A, Glampson B, Davies J, Papdimitriou D, Woods K, O'Gallagher K, Williams B, Asselbergs FW, Mayer EK, Lee R, Herbert C, Grant SW, Curzen N, Squire I, Kharbanda R, Shah A, Perera D, Patel RS, Channon K, Mayet J, Kaura A, Ben-Shlomo Y. Association between kidney function, frailty and receipt of invasive management after acute coronary syndrome. Open Heart. 2024 Oct 9;11(2):e002875. doi: 10.1136/openhrt-2024-002875. |
| 35192610 | Derived | Kaura A, Hartley A, Panoulas V, Glampson B, Shah ASV, Davies J, Mulla A, Woods K, Omigie J, Shah AD, Thursz MR, Elliott P, Hemmingway H, Williams B, Asselbergs FW, O'Sullivan M, Lord GM, Trickey A, Sterne JA, Haskard DO, Melikian N, Francis DP, Koenig W, Shah AM, Kharbanda R, Perera D, Patel RS, Channon KM, Mayet J, Khamis R. Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study. PLoS Med. 2022 Feb 22;19(2):e1003911. doi: 10.1371/journal.pmed.1003911. eCollection 2022 Feb. |
| 31748235 | Derived | Kaura A, Panoulas V, Glampson B, Davies J, Mulla A, Woods K, Omigie J, Shah AD, Channon KM, Weber JN, Thursz MR, Elliott P, Hemingway H, Williams B, Asselbergs FW, O'Sullivan M, Kharbanda R, Lord GM, Melikian N, Patel RS, Perera D, Shah AM, Francis DP, Mayet J. Association of troponin level and age with mortality in 250 000 patients: cohort study across five UK acute care centres. BMJ. 2019 Nov 20;367:l6055. doi: 10.1136/bmj.l6055. |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
|
| Secondary | Acute Revascularisation | Acute revascularisation will be defined as having PCI or CABG in the time window between 48 hours before and 3 months after the first troponin measurement. This will account for patients who had revascularisation, in particular PCI, as an emergency prior to their first troponin blood test and to capture revascularisation, in particular CABG, performed as an outpatient following their index admission. | 134,517 accounts for the number of patients 'admitted' to hospital, who had a troponin measured. | Posted | Count of Participants | Participants | 3 months follow-up |
|
|
|
| 55,850 |
| 257,948 |
| 0 |
| 0 |
| 0 |
| 0 |
Not provided
Not provided
Not provided